Erratum: Polysaccharide-Based Conjugates for Biomedical Applications (Bioconjugate Chemistry (2015) 26:8 (1396-1412) DOI: 10.1021/acs.bioconjchem.5b00242);Polysaccharide-Based Conjugates for Biomedical Applications

Bioconjugate Chemistry

Volumn 26, Issue 8, 2015, Pages 1396-1412

  Basu, Arijit ^a,b   Kunduru, Konda Reddy ^a   Abtew, Ester ^a   Domb, Abraham J ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b BIRLA INSTITUTE OF TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCOMPATIBILITY; CONTROLLED DRUG DELIVERY; GENE THERAPY; MEDICAL APPLICATIONS; TARGETED DRUG DELIVERY; TISSUE; TISSUE ENGINEERING;

BIOCONJUGATES; BIOMEDICAL APPLICATIONS; CONTROLLED RELEASE; HYDROPHILICS; HYDROPHOBIC MOIETIES; PH-RESPONSIVE; PHOTO-RESPONSIVE; SOLUBILISATION; THERMO-RESPONSIVE; TISSUES ENGINEERINGS;

POLYSACCHARIDES;

ADHESIVE AGENT; ALCOHOL; AMINE; ARABINOGALACTAN; CARBOHYDRATE; CARBOXYLIC ACID; CHITOSAN; CHONDROITIN; CYCLODEXTRIN; DEXTRAN; POLYSACCHARIDE; PULLULAN; VACCINE; BIOMATERIAL;

CLICK CHEMISTRY; CLINICAL TRIAL (TOPIC); CONJUGATE; CONJUGATION; DRUG DELIVERY SYSTEM; HUMAN; NONHUMAN; OXIDATION; PHASE 2 CLINICAL TRIAL (TOPIC); REVIEW; TISSUE ENGINEERING; CHEMISTRY; NANOTECHNOLOGY; PROCEDURES;

BIOCOMPATIBLE MATERIALS; NANOTECHNOLOGY; POLYSACCHARIDES; TISSUE ENGINEERING;

EID: 84939817023     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/acs.bioconjchem.6b00197     Document Type: Erratum

References (190)

1. Larson, N. and Ghandehari, H. (2012) Polymeric conjugates for drug delivery Chem. Mater. 24, 840-853 10.1021/cm2031569
2. Davis, B. G. and Robinson, M. A. (2002) Drug delivery systems based on sugar-macromolecule conjugates Curr. Opin. Drug Discovery Dev. 5, 279-288
3. Ringsdorf, H. (1975) J. Polym. Sci.: Polym. Symp. 51, 135-153
4. Shelke, N. B., James, R., Laurencin, C. T., and Kumbar, S. G. (2014) Polysaccharide biomaterials for drug delivery and regenerative engineering Polym. Adv. Technol. 25, 448-460 10.1002/pat.3266
5. Muntimadugu, E., Ickowicz, D. E., Domb, A. J., and Khan, W. (2013) Polysaccharide biomaterials Isr. J. Chem. 53, 787-794 10.1002/ijch.201300062
6. Mizrahy, S. and Peer, D. (2012) Polysaccharides as building blocks for nanotherapeutics Chem. Soc. Rev. 41, 2623-2640 10.1039/C1CS15239D
7. Shukla, R. K. and Tiwari, A. (2012) Carbohydrate polymers: Applications and recent advances in delivering drugs to the colon Carbohydr. Polym. 88, 399-416 10.1016/j.carbpol.2011.12.021
8. Goodarzi, N., Varshochian, R., Kamalinia, G., Atyabi, F., and Dinarvand, R. (2013) A review of polysaccharide cytotoxic drug conjugates for cancer therapy Carbohydr. Polym. 92, 1280-1293 10.1016/j.carbpol.2012.10.036
9. Jain, K., Kesharwani, P., Gupta, U., and Jain, N. K. (2012) A review of glycosylated carriers for drug delivery Biomaterials 33, 4166-4186 10.1016/j.biomaterials.2012.02.033
10. Domb, A. J. and Khan, W. (2013) Biodegradable Polymers as Drug Carrier Systems, in Polymers and Biomaterials (Dumitriu, S. and Popa, C., Eds.) pp 135-176, CRC Press.
11. Khan, W., Muthupandian, S., and Domb, A. J. (2013) Cationic Polymers for the Delivery of Therapeutic Nucleotides, in Nanotechnology for the delivery of therapeutic nucleic acids (Peer, D., Ed.) Pan Stanford Publishing.
12. Khan, W., Muthupandian, S., Farah, S., Kumar, N., and Domb, A. J. (2011) Biodegradable polymers derived from amino acids Macromol. Biosci. 11, 1625-1636 10.1002/mabi.201100324
13. Nair, L. S. and Laurencin, C. T. (2007) Biodegradable polymers as biomaterials Prog. Polym. Sci. 32, 762-798 10.1016/j.progpolymsci.2007.05.017
14. Liu, Z., Jiao, Y., Wang, Y., Zhou, C., and Zhang, Z. (2008) Polysaccharides-based nanoparticles as drug delivery systems Adv. Drug Delivery Rev. 60, 1650-1662 10.1016/j.addr.2008.09.001
15. Khan, W., Hosseinkhani, H., Ickowicz, D., Hong, P.-D., Yu, D.-S., and Domb, A. J. (2012) Polysaccharide gene transfection agents Acta Biomater. 8, 4224-4232 10.1016/j.actbio.2012.09.022
16. Baldwin, A. D. and Kiick, K. L. (2010) Polysaccharide modified synthetic polymeric biomaterials Biopolymers 94, 128-140 10.1002/bip.21334
17. Boddohi, S. and Kipper, M. J. (2010) Engineering nanoassemblies of polysaccharides Adv. Mater. 22, 2998-3016 10.1002/adma.200903790
18. Rinaudo, M. (2008) Main properties and current applications of some polysaccharides as biomaterials Polym. Int. 57, 397-430 10.1002/pi.2378
19. Croisier, F. and Jérôme, C. (2013) Chitosan-based biomaterials for tissue engineering Eur. Polym. J. 49, 780-792 10.1016/j.eurpolymj.2012.12.009
20. Cumpstey, I. (2013) Chemical modification of polysaccharides. International Scholarly Research Notices 2013. 1 10.1155/2013/417672
21. Lallana, E., Sousa-Herves, A., Fernandez-Trillo, F., Riguera, R., and Fernandez-Megia, E. (2012) Click chemistry for drug delivery nanosystems Pharm. Res. 29, 1-34 10.1007/s11095-011-0568-5
22. Varshosaz, J. (2012) Dextran conjugates in drug delivery Expert Opin. Drug Delivery 9, 509-523 10.1517/17425247.2012.673580
23. Elschner, T., Wondraczek, H., and Heinze, T. (2013) Syntheses and detailed structure characterization of dextran carbonates Carbohydr. Polym. 93, 216-223 10.1016/j.carbpol.2012.01.091
24. Rasheed, A., Krishna, U., Sivakrishna Reddy, P., and Mishra, A. (2011) Synthesis and characterization of novel dextran-conjugated macromolecules of aceclofenac ARS Pharm. 52, 5-11
25. Zhang, L., Li, Y., Wang, C., Li, G., Zhao, Y., and Yang, Y. (2014) Synthesis of methylprednisolone loaded ibuprofen modified inulin based nanoparticles and their application for drug delivery Mater. Sci. Eng., C 42, 111-115 10.1016/j.msec.2014.05.025
26. Elschner, T., Ganske, K., and Heinze, T. (2013) Synthesis and aminolysis of polysaccharide carbonates Cellulose 20, 339-353 10.1007/s10570-012-9819-9
27. Cui, L., Cohen, J. L., Chu, C. K., Wich, P. R., Kierstead, P. H., and Fréchet, J. M. J. (2012) Conjugation Chemistry through Acetals toward a Dextran-Based Delivery System for Controlled Release of siRNA J. Am. Chem. Soc. 134, 15840-15848 10.1021/ja305552u
28. Alves, N. M. and Mano, J. F. (2008) Chitosan derivatives obtained by chemical modifications for biomedical and environmental applications Int. J. Biol. Macromol. 43, 401-414 10.1016/j.ijbiomac.2008.09.007
29. Mourya, V. K. and Inamdar, N. N. (2008) Chitosan-modifications and applications: Opportunities galore React. Funct. Polym. 68, 1013-1051 10.1016/j.reactfunctpolym.2008.03.002
30. Park, S. Y., Baik, H. J., Oh, Y. T., Oh, K. T., Youn, Y. S., and Lee, E. S. (2011) A Smart Polysaccharide/Drug Conjugate for Photodynamic Therapy Angew. Chem., Int. Ed. 50, 1644-1647 10.1002/anie.201006038
31. Hu, L., Zhao, P., Deng, H., Xiao, L., Qin, C., Du, Y., and Shi, X. (2014) Electrical signal guided click coating of chitosan hydrogel on conductive surface RSC Adv. 4, 13477-13480 10.1039/c3ra47507g
32. Schanté, C. E., Zuber, G., Herlin, C., and Vandamme, T. F. (2011) Chemical modifications of hyaluronic acid for the synthesis of derivatives for a broad range of biomedical applications Carbohydr. Polym. 85, 469-489 10.1016/j.carbpol.2011.03.019
33. Yang, J.-S., Xie, Y.-J., and He, W. (2011) Research progress on chemical modification of alginate: A review Carbohydr. Polym. 84, 33-39 10.1016/j.carbpol.2010.11.048
34. Xu, X., Jha, A. K., Harrington, D. A., Farach-Carson, M. C., and Jia, X. (2012) Hyaluronic acid-based hydrogels: from a natural polysaccharide to complex networks Soft Matter 8, 3280-3294 10.1039/c2sm06463d
35. Kristiansen, K. A., Potthast, A., and Christensen, B. E. (2010) Periodate oxidation of polysaccharides for modification of chemical and physical properties Carbohydr. Res. 345, 1264-1271 10.1016/j.carres.2010.02.011
36. Parikka, K., Leppanen, A.-S., Pitkänen, L., Reunanen, M., Willfor, S., and Tenkanen, M. (2009) Oxidation of polysaccharides by galactose oxidase J. Agric. Food Chem. 58, 262-271 10.1021/jf902930t
37. Kachkarova-Sorokina, S. L., Gallezot, P., and Sorokin, A. B. (2004) A novel clean catalytic method for waste-free modification of polysaccharides by oxidation Chem. Commun. 2844-2845 10.1039/b411694a
38. Bragd, P., Van Bekkum, H., and Besemer, A. (2004) TEMPO-mediated oxidation of polysaccharides: survey of methods and applications Top. Catal. 27, 49-66 10.1023/B:TOCA.0000013540.69309.46
39. Zhang, F., Bernet, B., Bonnet, V., Dangles, O., Sarabia, F., and Vasella, A. (2008) 2-Azido-2-deoxycellulose: Synthesis and 1, 3-Dipolar Cycloaddition Helv. Chim. Acta 91, 608-617 10.1002/hlca.200890064
40. Hasegawa, T., Umeda, M., Numata, M., Li, C., Bae, A.-H., Fujisawa, T., Haraguchi, S., Sakurai, K., and Shinkai, S. (2006) Click chemistryon polysaccharides: a convenient, general, and monitorable approach to develop (1 3)-β-d-glucans with various functional appendages Carbohydr. Res. 341, 35-40 10.1016/j.carres.2005.10.009
41. Elchinger, P.-H., Faugeras, P.-A., Boëns, B., Brouillette, F., Montplaisir, D., Zerrouki, R., and Lucas, R. (2011) Polysaccharides: the click chemistry impact Polymers 3, 1607-1651 10.3390/polym3041607
42. Singh, V., Kumar, P., and Sanghi, R. (2012) Use of microwave irradiation in the grafting modification of the polysaccharides-A review Prog. Polym. Sci. 37, 340-364 10.1016/j.progpolymsci.2011.07.005
43. Bassi, P. F., Volpe, A., DAgostino, D., Palermo, G., Renier, D., Franchini, S., Rosato, A., and Racioppi, M. (2011) Paclitaxel-Hyaluronic Acid for Intravesical Therapy of Bacillus Calmette-Guérin Refractory Carcinoma In Situ of the Bladder: Results of a Phase I Study J. Urol. 185, 445-449 10.1016/j.juro.2010.09.073
44. Davis, M. E. (2009) Design and development of IT-101, a cyclodextrin-containing polymer conjugate of camptothecin Adv. Drug Delivery Rev. 61, 1189-1192 10.1016/j.addr.2009.05.005
45. Veltkamp, S. A., Witteveen, E. O., Capriati, A., Crea, A., Animati, F., Voogel-Fuchs, M., van den Heuvel, I. J. G. M., Beijnen, J. H., Voest, E. E., and Schellens, J. H. M. (2008) Clinical and Pharmacologic Study of the Novel Prodrug Delimotecan (MEN 4901/T-0128) in Patients with Solid Tumors Clin. Cancer Res. 14, 7535-7544 10.1158/1078-0432.CCR-08-0438
46. Soepenberg, O., de Jonge, M. J. A., Sparreboom, A., de Bruin, P., Eskens, F. A. L. M., de Heus, G., Wanders, J., Cheverton, P., Ducharme, M. P., and Verweij, J. (2005) Phase I and Pharmacokinetic Study of DE-310 in Patients with Advanced Solid Tumors Clin. Cancer. Res. 11, 703-711
47. Danhauser-Riedl, S., Hausmann, E., Schick, H.-D., Bender, R., Dietzfelbinger, H., Rastetter, J., and Hanauske, A.-R. (1993) Phase I clinical and pharmacokinetic trial of dextran conjugated doxorubicin (AD-70, DOX-OXD) Invest. New Drugs 11, 187-195 10.1007/BF00874153
48. Lim, C.-K., Shin, J., Kwon, I. C., Jeong, S. Y., and Kim, S. (2012) Iodinated photosensitizing chitosan: self-assembly into tumor-homing nanoparticles with enhanced singlet oxygen generation Bioconjugate Chem. 23, 1022-1028 10.1021/bc300012g
49. Li, X., Wu, P., Cheng, S., and Lv, X. (2012) Synthesis and Assessment of Globotriose-Chitosan Conjugate, a Novel Inhibitor of Shiga Toxins Produced by Escherichia coli J. Med. Chem. 55, 2702-2710 10.1021/jm201570s
50. Onishi, H., Shimoda, J., and Machida, Y. (1996) Chitosan-Drug Conjugate Microspheres: Preparation and Drug Release Properties of Microspheres Composed of the Conjugate of 2′- or 3′-(4-Carboxy-butyryl)-5- Fluorouridine with Chitosan Drug Dev. Ind. Pharm. 22, 457-463 10.3109/03639049609069355
51. Son, Y. J., Jang, J.-S., Cho, Y. W., Chung, H., Park, R.-W., Kwon, I. C., Kim, I.-S., Park, J. Y., Seo, S. B., Park, C. R., and Jeong, S. Y. (2003) Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effect J. Controlled Release 91, 135-145 10.1016/S0168-3659(03)00231-1
52. Lee, E., Lee, J., Lee, I.-H., Yu, M., Kim, H., Chae, S. Y., and Jon, S. (2008) Conjugated Chitosan as a Novel Platform for Oral Delivery of Paclitaxel J. Med. Chem. 51, 6442-6449 10.1021/jm800767c
53. Lee, E., Lee, J., and Jon, S. (2010) A Novel Approach to Oral Delivery of Insulin by Conjugating with Low Molecular Weight Chitosan Bioconjugate Chem. 21, 1720-1723 10.1021/bc100093v
54. Gong, X.-Y., Yin, Y.-H., Huang, Z.-J., Lu, B., Xu, P.-H., Zheng, H., Xiong, F.-L., Xu, H.-X., Xiong, X., and Gu, X.-B. (2012) Preparation, characterization and in vitro release study of a glutathione-dependent polymeric prodrug Cis-3-(9H-purin-6-ylthio)-acrylic acid-graft-carboxymethyl chitosan Int. J. Pharm. 436, 240-247 10.1016/j.ijpharm.2012.06.043
55. Yang, L., Chen, L., Zeng, R., Li, C., Qiao, R., Hu, L., and Li, Z. (2010) Synthesis, nanosizing and in vitro drug release of a novel anti-HIV polymeric prodrug: Chitosan-O-isopropyl-5′-O-d4T monophosphate conjugate Bioorg. Med. Chem. 18, 117-123 10.1016/j.bmc.2009.11.013
56. Yang, L., Zeng, R., Li, C., Li, G., Qiao, R., Hu, L., and Li, Z. (2009) Novel synthesis and in vitro drug release of polymeric prodrug: Chitosan-O-isopropyl-5′-O-d4T monophosphate conjugate Bioorg. Med. Chem. Lett. 19, 2566-2569 10.1016/j.bmcl.2009.03.044
57. Zeng, R., Wang, Z., Wang, H., Chen, L., Yang, L., Qiao, R., Hu, L., and Li, Z. (2012) Effect of bond linkage on in vitro drug release and anti-HIV activity of chitosan-stavudine conjugates Macromol. Res. 20, 358-365 10.1007/s13233-012-0022-5
58. Yousefpour, P., Atyabi, F., Vasheghani-Farahani, E., Movahedi, A.-A. M., and Dinarvand, R. (2011) Targeted delivery of doxorubicin-utilizing chitosan nanoparticles surface-functionalized with anti-Her2 trastuzumab Int. J. Nanomed. 6, 1977-1990 10.2147/IJN.S21523
59. Jiang, G.-B., Lin, Z.-T., Xu, X.-J., Hai, Z., and Song, K. (2012) Stable nanomicelles based on chitosan derivative: In vitro antiplatelet aggregation and adhesion properties Carbohydr. Polym. 88, 232-238 10.1016/j.carbpol.2011.11.089
60. Anwar, M., Warsi, M. H., Mallick, N., Akhter, S., Gahoi, S., Jain, G. K., Talegaonkar, S., Ahmad, F. J., and Khar, R. K. (2011) Enhanced bioavailability of nano-sized chitosan-atorvastatin conjugate after oral administration to rats Eur. J. Pharm. Sci. 44, 241-249 10.1016/j.ejps.2011.08.001
61. Huang, W., Wang, Y., Zhang, S., Huang, L., Hua, D., and Zhu, X. (2013) A facile approach for controlled modification of chitosan under -ray irradiation for drug delivery Macromolecules 46, 814-818 10.1021/ma302434c
62. Lian, H., Zhang, T., Sun, J., Liu, X., Ren, G., Kou, L., Zhang, Y., Han, X., Ding, W., and Ai, X. (2013) Enhanced oral delivery of paclitaxel using acetylcysteine functionalized chitosan-vitamin E succinate nanomicelles based on a mucus bioadhesion and penetration mechanism Mol. Pharmaceutics 10, 3447-3458 10.1021/mp400282r
63. Roy, A., Bhattacharyya, M., Ernsting, M. J., May, J. P., and Li, S. D. (2014) Recent progress in the development of polysaccharide conjugates of docetaxel and paclitaxel Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 6, 349-368 10.1002/wnan.1264
64. Zhao, Y., Zhang, X., Wang, Y., Wu, Z., An, J., Lu, Z., Mei, L., and Li, C. (2014) In situ cross-linked polysaccharide hydrogel as extracellular matrix mimics for antibiotics delivery Carbohydr. Polym. 105, 63-69 10.1016/j.carbpol.2014.01.068
65. Mero, A. and Campisi, M. (2014) Hyaluronic acid bioconjugates for the delivery of bioactive molecules Polymers 6, 346-369 10.3390/polym6020346
66. Cai, S., Thati, S., Bagby, T. R., Diab, H.-M., Davies, N. M., Cohen, M. S., and Forrest, M. L. (2010) Localized doxorubicin chemotherapy with a biopolymeric nanocarrier improves survival and reduces toxicity in xenografts of human breast cancer J. Controlled Release 146, 212-218 10.1016/j.jconrel.2010.04.006
67. Luo, Y., Bernshaw, N., Lu, Z.-R., Kopecek, J., and Prestwich, G. (2002) Targeted Delivery of Doxorubicin by HPMA Copolymer-Hyaluronan Bioconjugates Pharm. Res. 19, 396-402 10.1023/A:1015170907274
68. Auzenne, E., Ghosh, S. C., Khodadadian, M., Rivera, B., Farquhar, D., Price, R. E., Ravoori, M., Kundra, V., Freedman, R. S., and Klostergaard, J. (2007) Hyaluronic Acid- Paclitaxel: Antitumor Efficacy against CD44(+) Human Ovarian Carcinoma Xenografts Neoplasia 9, 479-486 10.1593/neo.07229
69. Luo, Y. and Prestwich, G. D. (1999) Synthesis and Selective Cytotoxicity of a Hyaluronic Acid-Antitumor Bioconjugate Bioconjugate Chem. 10, 755-763 10.1021/bc9900338
70. Luo, Y., Ziebell, M. R., and Prestwich, G. D. (2000) A Hyaluronic Acid-Taxol Antitumor Bioconjugate Targeted to Cancer Cells Biomacromolecules 1, 208-218 10.1021/bm000283n
71. Leonelli, F., La Bella, A., Francescangeli, A., Joudioux, R., Capodilupo, A.-L., Quagliariello, M., Migneco, L. M., Bettolo, R. M., Crescenzi, V., De Luca, G., and Renier, D. (2005) A New and Simply Available Class of Hydrosoluble Bioconjugates by Coupling Paclitaxel to Hyaluronic Acid through a 4-Hydroxybutanoic Acid Derived Linker Helv. Chim. Acta 88, 154-159 10.1002/hlca.200490289
72. Lee, H., Lee, K., and Park, T. G. (2008) Hyaluronic Acid-Paclitaxel Conjugate Micelles: Synthesis, Characterization, and Antitumor Activity Bioconjugate Chem. 19, 1319-1325 10.1021/bc8000485
73. Coradini, D., Pellizzaro, C., Miglierini, G., Daidone, M. G., and Perbellini, A. (1999) Hyaluronic acid as drug delivery for sodium butyrate: Improvement of the anti-proliferative activity on a breast-cancer cell line Int. J. Cancer 81, 411-416 10.1002/(SICI)1097-0215(19990505)81:3<411::AID-IJC15>3.3.CO;2-6
74. Manju, S. and Sreenivasan, K. (2011) Conjugation of curcumin onto hyaluronic acid enhances its aqueous solubility and stability J. Colloid Interface Sci. 359, 318-325 10.1016/j.jcis.2011.03.071
75. Homma, A., Sato, H., Okamachi, A., Emura, T., Ishizawa, T., Kato, T., Matsuura, T., Sato, S., Tamura, T., Higuchi, Y., Watanabe, T., Kitamura, H., Asanuma, K., Yamazaki, T., Ikemi, M., Kitagawa, H., Morikawa, T., Ikeya, H., Maeda, K., Takahashi, K., Nohmi, K., Izutani, N., Kanda, M., and Suzuki, R. (2009) Novel hyaluronic acid-methotrexate conjugates for osteoarthritis treatment Bioorg. Med. Chem. 17, 4647-4656 10.1016/j.bmc.2009.04.063
76. Homma, A., Sato, H., Tamura, T., Okamachi, A., Emura, T., Ishizawa, T., Kato, T., Matsuura, T., Sato, S., Higuchi, Y., Watanabe, T., Kitamura, H., Asanuma, K., Yamazaki, T., Ikemi, M., Kitagawa, H., Morikawa, T., Ikeya, H., Maeda, K., Takahashi, K., Nohmi, K., Izutani, N., Kanda, M., and Suzuki, R. (2010) Synthesis and optimization of hyaluronic acid-methotrexate conjugates to maximize benefit in the treatment of osteoarthritis Bioorg. Med. Chem. 18, 1062-1075 10.1016/j.bmc.2009.12.053
77. Li, N., Chen, Y., Zhang, Y.-M., Yang, Y., Su, Y., Chen, J.-T., and Liu, Y. (2014) Polysaccharide-gold nanocluster supramolecular conjugates as a versatile platform for the targeted delivery of anticancer drugs Sci. Rep. 4, 4164 10.1038/srep04164
78. Goh, E. J., Kim, K. S., Kim, Y. R., Jung, H. S., Beack, S., Kong, W. H., Scarcelli, G., Yun, S. H., and Hahn, S. K. (2012) Bioimaging of hyaluronic acid derivatives using nanosized carbon dots Biomacromolecules 13, 2554-2561 10.1021/bm300796q
79. Yao, J., Zhang, L., Zhou, J., Liu, H., and Zhang, Q. (2013) Efficient simultaneous tumor targeting delivery of all-trans retinoid acid and paclitaxel based on hyaluronic acid-based multifunctional nanocarrier Mol. Pharmaceutics 10, 1080-1091 10.1021/mp3005808
80. Lee, M.-Y., Yang, J.-A., Jung, H. S., Beack, S., Choi, J. E., Hur, W., Koo, H., Kim, K., Yoon, S. K., and Hahn, S. K. (2012) Hyaluronic Acid-Gold Nanoparticle/Interferon α Complex for Targeted Treatment of Hepatitis C Virus Infection ACS Nano 6, 9522-9531 10.1021/nn302538y
81. Yang, J. S., Zhou, Q. Q., and He, W. (2013) Amphipathicity and self-assembly behavior of amphiphilic alginate esters Carbohydr. Polym. 92, 223-227 10.1016/j.carbpol.2012.08.100
82. Yang, J. S., Jiang, B., He, W., and Xia, Y. M. (2012) Hydrophobically modified alginate for emulsion of oil in water Carbohydr. Polym. 87, 1503-1506 10.1016/j.carbpol.2011.09.046
83. Dey, S. and Sreenivasan, K. (2014) Conjugation of curcumin onto alginate enhances aqueous solubility and stability of curcumin Carbohydr. Polym. 99, 499-507 10.1016/j.carbpol.2013.08.067
84. Wang, Y., Zhou, J., Qiu, L., Wang, X., Chen, L., Liu, T., and Di, W. (2014) Cisplatin-alginate conjugate liposomes for targeted delivery to EGFR-positive ovarian cancer cells Biomaterials 35, 4297-4309 10.1016/j.biomaterials.2014.01.035
85. Couvreur, P. (2014) Drug delivery: Replenishing reservoirs in vivo Nat. Nanotechnol. 9, 874-875 10.1038/nnano.2014.253
86. Brudno, Y., Silva, E. A., Kearney, C. J., Lewin, S. A., Miller, A., Martinick, K. D., Aizenberg, M., and Mooney, D. J. (2014) Refilling drug delivery depots through the blood Proc. Natl. Acad. Sci. U. S. A. 111, 12722-12727 10.1073/pnas.1413027111
87. Saha, S., Chhatbar, M. U., Mahato, P., Praveen, L., Siddhanta, A., and Das, A. (2012) Rhodamine-alginate conjugate as self indicating gel beads for efficient detection and scavenging of Hg 2+ and Cr 3+ in aqueous media Chem. Commun. 48, 1659-1661 10.1039/C1CC16554B
88. Yu, C., Gao, C., Lü, S., Chen, C., Yang, J., Di, X., and Liu, M. (2014) Facile preparation of pH-sensitive micelles self-assembled from amphiphilic chondroitin sulfate-histamine conjugate for triggered intracellular drug release Colloids Surf., B 115, 331-339 10.1016/j.colsurfb.2013.12.023
89. Bishnoi, M., Jain, A., Hurkat, P., and Jain, S. K. (2014) Aceclofenac-loaded chondroitin sulfate conjugated SLNs for effective management of osteoarthritis J. Drug Targeting 22, 805-812 10.3109/1061186X.2014.928714
90. Sugahara, S.-i., Kajiki, M., Kuriyama, H., and Kobayashi, T.-r. (2007) Complete regression of xenografted human carcinomas by a paclitaxel-carboxymethyl dextran conjugate (AZ10992) J. Controlled Release 117, 40-50 10.1016/j.jconrel.2006.10.009
91. Sugahara, S.-i., Kajiki, M., Kuriyama, H., and Kobayashi, T.-r. (2008) Carrier effects on antitumor activity and neurotoxicity of AZ10992, a paclitaxel-carboxymethyl dextran conjugate, in a mouse model Biol. Pharm. Bull. 31, 223-230 10.1248/bpb.31.223
92. Harada, M., Imai, J., Okuno, S., and Suzuki, T. (2000) Macrophage-mediated activation of camptothecin analogue T-2513-carboxymethyl dextran conjugate (T-0128): possible cellular mechanism for antitumor activity J. Controlled Release 69, 389-397 10.1016/S0168-3659(00)00320-5
93. Harada, M., Murata, J.-i., Sakamura, Y., Sakakibara, H., Okuno, S., and Suzuki, T. (2001) Carrier and dose effects on the pharmacokinetics of T-0128, a camptothecin analogue-carboxymethyl dextran conjugate, in non-tumor- and tumor-bearing rats J. Controlled Release 71, 71-86 10.1016/S0168-3659(00)00372-2
94. Harada, M., Sakakibara, H., Yano, T., Suzuki, T., and Okuno, S. (2000) Determinants for the drug release from T-0128, camptothecin analogue-carboxymethyl dextran conjugate J. Controlled Release 69, 399-412 10.1016/S0168-3659(00)00321-7
95. Okuno, S., Harada, M., Yano, T., Yano, S., Kiuchi, S., Tsuda, N., Sakamura, Y., Imai, J., Kawaguchi, T., and Tsujihara, K. (2000) Complete Regression of Xenografted Human Carcinomas by Camptothecin Analogue-Carboxymethyl Dextran Conjugate (T-0128) Cancer Res. 60, 2988-2995
96. Inoue, K., Kumazawa, E., Kuga, H., Susaki, H., Masubuchi, N., and Kajimura, T. (2003) CM-Dextran-Polyalcohol-Camptothecin Conjugate, in Polymer Drugs in the Clinical Stage (Maeda, H., Kabanov, A., Kataoka, K., and Okano, T., Eds.) pp 145-153, Springer, New York.
97. Ochi, Y., Shiose, Y., Kuga, H., and Kumazawa, E. (2005) A possible mechanism for the long-lasting antitumor effect of the macromolecular conjugate DE-310: mediation by cellular uptake and drug release of its active camptothecin analog DX-8951 Cancer Chemother. Pharmacol. 55, 323-332 10.1007/s00280-004-0911-1
98. Onishi, H., Seno, Y., Pithayanukul, P., and Nagai, T. (1991) Conjugate of N4-(4-carboxybutyryl)-ara-C and ethylenediamine-introduced dextran. Drug release profiles and further in vivo study of its antitumor effects Drug Des. Delivery 7, 139-145
99. Dang, W., Colvin, O. M., Brem, H., and Saltzman, W. M. (1994) Covalent Coupling of Methotrexate to Dextran Enhances the Penetration of Cytotoxicity into a Tissue-like Matrix Cancer Res. 54, 1729-1735
100. Nevozhay, D., Budzynska, R., Jagiello, M., Kanska, U., Omar, M. S., Opolski, A., Wietrzyk, J., and Boratynski, J. (2006) The Effect of the Substitution Level of Some Dextran-methotrexate Conjugates on their Antitumor Activity in Experimental Cancer Models Anticancer Res. 26, 2179-2186
101. Nevozhay, D., Budzynska, R., Kanska, U., Jagiello, M., Omar, M. S., Boratynski, J., and Opolski, A. (2006) Antitumor Properties and Toxicity of Dextran-methotrexate Conjugates are Dependent on the Molecular Weight of the Carrier Anticancer Res. 26, 1135-1143
102. Chau, Y., Tan, F. E., and Langer, R. (2004) Synthesis and Characterization of Dextran-Peptide-Methotrexate Conjugates for Tumor Targeting via Mediation by Matrix Metalloproteinase II and Matrix Metalloproteinase IX Bioconjugate Chem. 15, 931-941 10.1021/bc0499174
103. Chau, Y., Padera, R. F., Dang, N. M., and Langer, R. (2006) Antitumor efficacy of a novel polymer-peptide-drug conjugate in human tumor xenograft models Int. J. Cancer 118, 1519-1526 10.1002/ijc.21495
104. Chau, Y., Dang, N. M., Tan, F. E., and Langer, R. (2006) Investigation of targeting mechanism of new dextran-peptide-methotrexate conjugates using biodistribution study in matrix-metalloproteinase-overexpressing tumor xenograft model J. Pharm. Sci. 95, 542-551 10.1002/jps.20548
105. Zhou, C., Gao, W., Lu, G., Ding, J., Wu, X., Huang, X., Chen, J., Liu, M., Jiang, J., and Wu, H. (2013) Preparation, characterization and in vitro release of microparticles based on dextran-rosuvastatin conjugate Carbohydr. Polym. 96, 156-162 10.1016/j.carbpol.2013.03.094
106. Ferguson, E. L., Azzopardi, E., Roberts, J. L., Walsh, T. R., and Thomas, D. W. (2014) Dextrin-Colistin Conjugates as a Model Bioresponsive Treatment for Multidrug Resistant Bacterial Infections Mol. Pharmaceutics 11, 4437-4447 10.1021/mp500584u
107. Li, F., Zhang, H., Gu, C., Fan, L., Qiao, Y., Tao, Y., Cheng, C., Wu, H., and Yi, J. (2013) Self-assembled nanoparticles from folate-decorated maleilated pullulan-doxorubicin conjugate for improved drug delivery to cancer cells Polym. Int. 62, 165-171 10.1002/pi.4272
108. Cai, X., Yang, L., Zhang, L.-M., and Wu, Q. (2009) Synthesis and anaerobic biodegradation of indomethacin-conjugated cellulose ethers used for colon-specific drug delivery Bioresour. Technol. 100, 4164-4170 10.1016/j.biortech.2009.04.005
109. Jung, S., Swamy, B. Y., Moon, J.-B., Kim, D.-H., and Chung, I. (2012) Anti-AIDS active polyrotaxane-AZT conjugates with bioactive bulky stoppers and their nanoparticles J. Polym. Sci., Part A: Polym. Chem. 50, 4895-4901 10.1002/pola.26317
110. Jin, R., Ji, X., Yang, Y., Wang, H., and Cao, A. (2013) Self-Assembled Graphene-Dextran Nanohybrid for Killing Drug-Resistant Cancer Cells ACS Appl. Mater. Interfaces 5, 7181-7189 10.1021/am401523y
111. Kang, S. W., Lee, Y. W., Park, Y., Choi, B.-S., Hong, J. W., Park, K.-H., and Han, S. W. (2013) One-Pot Synthesis of Trimetallic Au@ PdPt Core-Shell Nanoparticles with High Catalytic Performance ACS Nano 7, 7945-7955 10.1021/nn403027j
112. Falk, R., Domb, A. J., and Polacheck, I. (1999) A novel injectable water-soluble amphotericin B-arabinogalactan conjugate Antimicrob. Agents Chemother. 43, 1975-1981
113. Ehrenfreund-Kleinman, T., Azzam, T., Falk, R., Polacheck, I., Golenser, J., and Domb, A. (2002) Synthesis and characterization of novel water soluble amphotericin B-arabinogalactan conjugates Biomaterials 23, 1327-1335 10.1016/S0142-9612(01)00251-4
114. Sokolsky-Papkov, M., Domb, A. J., and Golenser, J. (2006) Impact of aldehyde content on amphotericin B-dextran imine conjugate toxicity Biomacromolecules 7, 1529-1535 10.1021/bm050747n
115. Ehrenfreund-Kleinman, T., Golenser, J., and Domb, A. J. (2004) Conjugation of amino-containing drugs to polysaccharides by tosylation: amphotericin B-arabinogalactan conjugates Biomaterials 25, 3049-3057 10.1016/j.biomaterials.2003.09.080
116. Elgart, A., Farber, S., Domb, A. J., Polacheck, I., and Hoffman, A. (2010) Polysaccharide Pharmacokinetics: Amphotericin B Arabinogalactan Conjugate-A Drug Delivery System or a New Pharmaceutical Entity? Biomacromolecules 11, 1972-1977 10.1021/bm100298r
117. Kagan, S., Ickowicz, D., Shmuel, M., Altschuler, Y., Sionov, E., Pitusi, M., Weiss, A., Farber, S., Domb, A. J., and Polacheck, I. (2012) Toxicity mechanisms of amphotericin B and its neutralization by conjugation with arabinogalactan Antimicrob. Agents Chemother. 56, 5603-5611 10.1128/AAC.00612-12
118. Ickowicz, D. E., Farber, S., Sionov, E., Kagan, S., Hoffman, A., Polacheck, I., and Domb, A. J. (2014) Activity, Reduced Toxicity, and Scale-Up Synthesis of Amphotericin B-Conjugated Polysaccharide Biomacromolecules 15, 2079-2089 10.1021/bm5002125
119. Golenser, J. and Domb, A. (2006) New formulations and derivatives of amphotericin B for treatment of leishmaniasis Mini-Rev. Med. Chem. 6, 153-162
120. Ehrenfreund-Kleinman, T., Domb, A. J., Jaffe, C. L., Nasereddin, A., Leshem, B., and Golenser, J. (2005) The effect of amphotericin b derivatives on Leishmania and immune functions J. Parasitol. 91, 158-163 10.1645/GE-3379
121. Falk, R., Grunwald, J., Hoffman, A., Domb, A. J., and Polacheck, I. (2004) Distribution of amphotericin B-arabinogalactan conjugate in mouse tissue and its therapeutic efficacy against murine aspergillosis Antimicrob. Agents Chemother. 48, 3606-3609 10.1128/AAC.48.9.3606-3609.2004
122. Falk, R., Hacham, M., Nyska, A., Foley, J. F., Domb, A. J., and Polacheck, I. (2005) Induction of interleukin-1β, tumour necrosis factor-α and apoptosis in mouse organs by amphotericin B is neutralized by conjugation with arabinogalactan J. Antimicrob. Chemother. 55, 713-720 10.1093/jac/dki090
123. Pinhassi, R. I., Assaraf, Y. G., Farber, S., Stark, M., Ickowicz, D., Drori, S., Domb, A. J., and Livney, Y. D. (2010) Arabinogalactan-Folic Acid-Drug Conjugate for Targeted Delivery and Target-Activated Release of Anticancer Drugs to Folate Receptor-Overexpressing Cells Biomacromolecules 11, 294-303 10.1021/bm900853z
124. Bonzi, G., Salmaso, S., Scomparin, A., Eldar-Boock, A., Satchi-Fainaro, R., and Caliceti, P. (2015) A novel pullulan bioconjugate for selective breast cancer bone metastases treatment Bioconjugate Chem. 26, 489-501 10.1021/bc500614b
125. Azzam, T. and Domb, A. J. (2004) Current developments in gene transfection agents Curr. Drug Delivery 1, 165-193
126. Khan, W., Hosseinkhani, H., Ickowicz, D., Hong, P.-D., Yu, D.-S., and Domb, A. J. (2012) Polysaccharide gene transfection agents Acta Biomater. 8, 4224-4232 10.1016/j.actbio.2012.09.022
127. Israel, Z. H. and Domb, A. J. (1998) Polymers in gene therapy: antisense delivery systems Polym. Adv. Technol. 9, 799-805 10.1002/(SICI)1099-1581(1998100)9:10/11<799::AID-PAT807>3.0.CO;2-N
128. Wang, W., Li, W., Ma, N., and Steinhoff, G. (2013) Non-viral gene delivery methods Curr. Pharm. Biotechnol. 14, 46-60 10.2174/138920113804805278
129. Eliyahu, H., Barenholz, Y., and Domb, A. (2005) Polymers for DNA delivery Molecules 10, 34-64 10.3390/10010034
130. Biju, V. (2014) Chemical modifications and bioconjugate reactions of nanomaterials for sensing, imaging, drug delivery and therapy Chem. Soc. Rev. 43, 744-764 10.1039/C3CS60273G
131. Lai, W.-F. (2014) Cyclodextrins in non-viral gene delivery Biomaterials 35, 401-411 10.1016/j.biomaterials.2013.09.061
132. Yudovin-Farber, I., Yanay, C., Azzam, T., Linial, M., and Domb, A. J. (2005) Quaternary Ammonium Polysaccharides for Gene Delivery Bioconjugate Chem. 16, 1196-1203 10.1021/bc050066p
133. Azzam, T., Eliyahu, H., Shapira, L., Linial, M., Barenholz, Y., and Domb, A. J. (2002) Polysaccharide-Oligoamine Based Conjugates for Gene Delivery J. Med. Chem. 45, 1817-1824 10.1021/jm0105528
134. Azzam, T., Eliyahu, H., Makovitzki, A., and Domb, A. J. (2003) Dextran-spermine conjugate: an efficient vector for gene delivery Macromol. Symp. 195, 247-262 10.1002/masy.200390130
135. Yeo, W. W. Y., Hosseinkhani, H., Rahman, S. A., Rosli, R., Domb, A. J., and Abdullah, S. (2014) Safety profile of dextran-spermine gene delivery vector in mouse lungs J. Nanosci. Nanotechnol. 14, 3328-3336 10.1166/jnn.2014.8073
136. Abedini, F., Ismail, M., Hosseinkhani, H., Ibrahim, T., Azmi, T., Omar, A., Chong, P. P., Ismail, N., Farber, I.-Y., and Domb, A. J. (2010) Toxicity evaluation of dextran-spermine polycation as a tool for genetherapy in vitro J. Cell Animal Biol. 4, 170-176
137. Azzam, T., Raskin, A., Makovitzki, A., Brem, H., Vierling, P., Lineal, M., and Domb, A. J. (2002) Cationic polysaccharides for gene delivery Macromolecules 35, 9947-9953 10.1021/ma0209592
138. Hosseinkhani, H., Azzam, T., Tabata, Y., and Domb, A. J. (2004) Dextran-spermine polycation: an efficient nonviral vector for in vitro and in vivo gene transfection Gene Ther. 11, 194-203 10.1038/sj.gt.3302159
139. Yudovin-Farber, I. and Domb, A. J. (2007) Cationic polysaccharides for gene delivery Mater. Sci. Eng., C 27, 595-598 10.1016/j.msec.2006.05.044
140. Eliyahu, H., Joseph, A., Schillemans, J. P., Azzam, T., Domb, A. J., and Barenholz, Y. (2007) Characterization and in vivo performance of dextran-spermine polyplexes and DOTAP/cholesterol lipoplexes administered locally and systemically Biomaterials 28, 2339-2349 10.1016/j.biomaterials.2006.09.001
141. Hosseinkhani, H., Azzam, T., Kobayashi, H., Hiraoka, Y., Shimokawa, H., Domb, A. J., and Tabata, Y. (2006) Combination of 3D tissue engineered scaffold and non-viral gene carrier enhance in vitro DNA expression of mesenchymal stem cells Biomaterials 27, 4269-4278 10.1016/j.biomaterials.2006.02.033
142. Eliyahu, H., Makovitzki, A., Azzam, T., Zlotkin, A., Joseph, A., Gazit, D., Barenholz, Y., and Domb, A. J. (2005) Novel dextran-spermine conjugates as transfecting agents: comparing water-soluble and micellar polymers Gene Ther. 12, 494-503 10.1038/sj.gt.3302395
143. Azzam, T., Eliyahu, H., Makovitzki, A., Linial, M., and Domb, A. J. (2004) Hydrophobized dextran-spermine conjugate as potential vector for in vitro gene transfection J. Controlled Release 96, 309-323 10.1016/j.jconrel.2004.01.022
144. Amini, R., Jalilian, F. A., Abdullah, S., Veerakumarasivam, A., Hosseinkhani, H., Abdulamir, A. S., Domb, A. J., Ickowicz, D., and Rosli, R. (2013) Dynamics of PEGylated-Dextran-Spermine Nanoparticles for Gene Delivery to Leukemic Cells Appl. Biochem. Biotechnol. 170, 841-853 10.1007/s12010-013-0224-0
145. Mohan, T., Kargl, R., Köstler, S., Doliška, A., Findenig, G., Ribitsch, V., and Stana-Kleinschek, K. (2012) Functional polysaccharide conjugates for the preparation of microarrays ACS Appl. Mater. Interfaces 4, 2743-2751 10.1021/am300375m
146. Rekha, M. R. and Sharma, C. P. (2011) Hemocompatible pullulan-polyethyleneimine conjugates for liver cell gene delivery: In vitro evaluation of cellular uptake, intracellular trafficking and transfection efficiency Acta Biomater. 7, 370-379 10.1016/j.actbio.2010.07.027
147. Xu, F. J., Ping, Y., Ma, J., Tang, G. P., Yang, W. T., Li, J., Kang, E. T., and Neoh, K. G. (2009) Comb-shaped copolymers composed of hydroxypropyl cellulose backbones and cationic poly((2-dimethyl amino)ethyl methacrylate) side chains for gene delivery Bioconjugate Chem. 20, 1449-1458 10.1021/bc900044h
148. Cui, L., Cohen, J. L., Chu, C. K., Wich, P. R., Kierstead, P. H., and Fréchet, J. M. (2012) Conjugation chemistry through acetals toward a dextran-based delivery system for controlled release of siRNA J. Am. Chem. Soc. 134, 15840-15848 10.1021/ja305552u
149. Liu, Y., Wang, Y., Zhang, C., Zhou, P., Liu, Y., An, T., Sun, D., Zhang, N., and Wang, Y. (2014) Core-Shell Nanoparticles Based on Pullulan and Poly (β-amino) Ester for Hepatoma-Targeted Codelivery of Gene and Chemotherapy Agent ACS Appl. Mater. Interfaces 6, 18712-18720 10.1021/am504203x
150. Morimoto, N., Hirano, S., Takahashi, H., Loethen, S., Thompson, D. H., and Akiyoshi, K. (2013) Self-assembled pH-sensitive cholesteryl pullulan nanogel as a protein delivery vehicle Biomacromolecules 14, 56-63 10.1021/bm301286h
151. Mo, Y., Wang, H., Liu, J., Lan, Y., Guo, R., Zhang, Y., Xue, W., and Zhang, Y. (2015) Controlled release and targeted delivery to cancer cells of doxorubicin from polysaccharide-functionalised single-walled carbon nanotubes J. Mater. Chem. B 3, 1846-1855 10.1039/C4TB02123A
152. Cremers, H. F. M., Feijen, J., Kwon, G., Bae, Y. H., Kim, S. W., Noteborn, H. P. J. M., and McVie, J. G. (1990) Albumin-heparin microspheres as carriers for cytostatic agents J. Controlled Release 11, 167-179 10.1016/0168-3659(90)90130-L
153. Li, L., Kim, J. K., Huh, K. M., Lee, Y.-k., and Kim, S. Y. (2012) Targeted delivery of paclitaxel using folate-conjugated heparin-poly(β-benzyl-l-aspartate) self-assembled nanoparticles Carbohydr. Polym. 87, 2120-2128 10.1016/j.carbpol.2011.10.030
154. Svenson, S., Wolfgang, M., Hwang, J., Ryan, J., and Eliasof, S. (2011) Preclinical to clinical development of the novel camptothecin nanopharmaceutical CRLX101 J. Controlled Release 153, 49-55 10.1016/j.jconrel.2011.03.007
155. Young, C., Schluep, T., Hwang, J., and Eliasof, S. (2011) CRLX101 (formerly IT-101)-A Novel Nanopharmaceutical of Camptothecin in Clinical Development Curr. Bioactive Comp. 7, 8-14
156. Luo, Y. and Prestwich, G. D. (1999) Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate Bioconjugate Chem. 10, 755-763 10.1021/bc9900338
157. Khan, F. and Ahmad, S. R. (2013) Polysaccharides and Their Derivatives for Versatile Tissue Engineering Application Macromol. Biosci. 13, 395-421 10.1002/mabi.201200409
158. Di Martino, A., Sittinger, M., and Risbud, M. V. (2005) Chitosan: A versatile biopolymer for orthopaedic tissue-engineering Biomaterials 26, 5983-5990 10.1016/j.biomaterials.2005.03.016
159. Wang, D.-A., Varghese, S., Sharma, B., Strehin, I., Fermanian, S., Gorham, J., Fairbrother, D. H., Cascio, B., and Elisseeff, J. H. (2007) Multifunctional chondroitin sulphate for cartilage tissue-biomaterial integration Nat. Mater. 6, 385-392 10.1038/nmat1890
160. Lauder, R. M. (2009) Chondroitin sulphate: a complex molecule with potential impacts on a wide range of biological systems Comp. Ther. Med. 17, 56-62 10.1016/j.ctim.2008.08.004
161. Volpi, N. (1997) Inhibition of human leukocyte elastase activity by chondroitin sulfates Chem.-Biol. Interact. 105, 157-167 10.1016/S0009-2797(97)00045-8
162. Campbell, E. J. and Owen, C. A. (2007) The sulfate groups of chondroitin sulfate-and heparan sulfate-containing proteoglycans in neutrophil plasma membranes are novel binding sites for human leukocyte elastase and cathepsin G J. Biol. Chem. 282, 14645-14654 10.1074/jbc.M608346200
163. Legendre, F., Baugé, C., Roche, R., Saurel, A., and Pujol, J. (2008) Chondroitin sulfate modulation of matrix and inflammatory gene expression in IL-1β-stimulated chondrocytes-study in hypoxic alginate bead cultures Osteoarthritis Cartilage 16, 105-114 10.1016/j.joca.2007.05.020
164. Tat, S. K., Pelletier, J.-P., Vergés, J., Lajeunesse, D., Montell, E., Fahmi, H., Lavigne, M., and Martel-Pelletier, J. (2007) Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts: a basic science study Arthrit. Res. Ther. 9, R117 10.1186/ar2325
165. Simmons, C. A., Alsberg, E., Hsiong, S., Kim, W. J., and Mooney, D. J. (2004) Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells Bone 35, 562-569 10.1016/j.bone.2004.02.027
166. Alsberg, E., Kong, H. J., Hirano, Y., Smith, M. K., Albeiruti, A., and Mooney, D. J. (2003) Regulating Bone Formation via Controlled Scaffold Degradation J. Dent. Res. 82, 903-908 10.1177/154405910308201111
167. Prestwich, G. D. (2011) Hyaluronic acid-based clinical biomaterials derived for cell and molecule delivery in regenerative medicine J. Controlled Release 155, 193-199 10.1016/j.jconrel.2011.04.007
168. Patterson, J., Siew, R., Herring, S. W., Lin, A. S. P., Guldberg, R., and Stayton, P. S. (2010) Hyaluronic acid hydrogels with controlled degradation properties for oriented bone regeneration Biomaterials 31, 6772-6781 10.1016/j.biomaterials.2010.05.047
169. Bae, M. S., Yang, D. H., Lee, J. B., Heo, D. N., Kwon, Y.-D., Youn, I. C., Choi, K., Hong, J. H., Kim, G. T., Choi, Y. S., Hwang, E. H., and Kwon, I. K. (2011) Photo-cured hyaluronic acid-based hydrogels containing simvastatin as a bone tissue regeneration scaffold Biomaterials 32, 8161-8171 10.1016/j.biomaterials.2011.07.045
170. Kim, J., Kim, I. S., Cho, T. H., Kim, H. C., Yoon, S. J., Choi, J., Park, Y., Sun, K., and Hwang, S. J. (2010) In vivo evaluation of MMP sensitive high-molecular weight HA-based hydrogels for bone tissue engineering J. Biomed. Mater. Res., Part A 95A, 673-681 10.1002/jbm.a.32884
171. Kim, J., Kim, I. S., Cho, T. H., Lee, K. B., Hwang, S. J., Tae, G., Noh, I., Lee, S. H., Park, Y., and Sun, K. (2007) Bone regeneration using hyaluronic acid-based hydrogel with bone morphogenic protein-2 and human mesenchymal stem cells Biomaterials 28, 1830-1837 10.1016/j.biomaterials.2006.11.050
172. Rinaudo, M. (2008) Main properties and current applications of some polysaccharides as biomaterials Polym. Int. 57, 397-430 10.1002/pi.2378
173. Jing, J., Fournier, A., Szarpak-Jankowska, A., Block, M. R., and Auzély-Velty, R. (2015) Type, Density, and Presentation of Grafted Adhesion Peptides on Polysaccharide-Based Hydrogels Control Preosteoblast Behavior and Differentiation Biomacromolecules 16, 715-722 10.1021/bm501613u
174. Bidarra, S. J., Barrias, C. C., and Granja, P. L. (2014) Injectable alginate hydrogels for cell delivery in tissue engineering Acta Biomater. 10, 1646-1662 10.1016/j.actbio.2013.12.006
175. Bouten, P. J., Zonjee, M., Bender, J., Yauw, S. T., van Goor, H., van Hest, J. C., and Hoogenboom, R. (2014) The chemistry of tissue adhesive materials Prog. Polym. Sci. 39, 1375-1405 10.1016/j.progpolymsci.2014.02.001
176. Tillet, G., Boutevin, B., and Ameduri, B. (2011) Chemical reactions of polymer crosslinking and post-crosslinking at room and medium temperature Prog. Polym. Sci. 36, 191-217 10.1016/j.progpolymsci.2010.08.003
177. Ono, K., Saito, Y., Yura, H., Ishikawa, K., Kurita, A., Akaike, T., and Ishihara, M. (2000) Photocrosslinkable chitosan as a biological adhesive J. Biomed. Mater. Res. 49, 289-295 10.1002/(SICI)1097-4636(200002)49:2<289::AID-JBM18>3.3.CO;2-D
178. Wang, T., Nie, J., and Yang, D. (2012) Dextran and gelatin based photocrosslinkable tissue adhesive Carbohydr. Polym. 90, 1428-1436 10.1016/j.carbpol.2012.07.011
179. Serrero, A., Trombotto, S., Bayon, Y., Gravagna, P., Montanari, S., and David, L. (2011) Polysaccharide-based adhesive for biomedical applications: correlation between rheological behavior and adhesion Biomacromolecules 12, 1556-1566 10.1021/bm101505r
180. Giano, M. C., Ibrahim, Z., Medina, S. H., Sarhane, K. A., Christensen, J. M., Yamada, Y., Brandacher, G., and Schneider, J. P. (2014) Injectable bioadhesive hydrogels with innate antibacterial properties Nat. Commun. 5, 1-9 10.1038/ncomms5095
181. Berillo, D., Elowsson, L., and Kirsebom, H. (2012) Oxidized dextran as crosslinker for chitosan cryogel scaffolds and formation of polyelectrolyte complexes between chitosan and gelatin Macromol. Biosci. 12, 1090-1099 10.1002/mabi.201200023
182. Strehin, I., Nahas, Z., Arora, K., Nguyen, T., and Elisseeff, J. (2010) A versatile pH sensitive chondroitin sulfate-PEG tissue adhesive and hydrogel Biomaterials 31, 2788-2797 10.1016/j.biomaterials.2009.12.033
183. Kramer, K., Senninger, N., Herbst, H., and Probst, W. (2002) Effective prevention of adhesions with hyaluronate Arch. Surg. 137, 137-278 10.1001/archsurg.137.3.278
184. Peak, C. W., Wilker, J. J., and Schmidt, G. (2013) A review on tough and sticky hydrogels Colloid Polym. Sci. 291, 2031-2047 10.1007/s00396-013-3021-y
185. Rappuoli, R. and De Gregorio, E. (2011) A sweet T cell response Nat. Med. 17, 1551-1552 10.1038/nm.2587
186. Gamblin, D. P., Scanlan, E. M., and Davis, B. G. (2009) Glycoprotein synthesis: an update Chem. Rev. 109, 131-163 10.1021/cr078291i
187. Mura, S., Nicolas, J., and Couvreur, P. (2013) Stimuli-responsive nanocarriers for drug delivery Nat. Mater. 12, 991-1003 10.1038/nmat3776
188. Qiu, X. and Hu, S. (2013) Smart materials based on cellulose: A review of the preparations, properties, and applications Materials 6, 738-781 10.3390/ma6030738
189. Alvarez-Lorenzo, C., Blanco-Fernandez, B., Puga, A. M., and Concheiro, A. (2013) Crosslinked ionic polysaccharides for stimuli-sensitive drug delivery Adv. Drug Delivery Rev. 65, 1148-1171 10.1016/j.addr.2013.04.016
190. Kim, S., Kim, J.-H., Jeon, O., Kwon, I. C., and Park, K. (2009) Engineered polymers for advanced drug delivery Eur. J. Pharm. Biopharm. 71, 420-430 10.1016/j.ejpb.2008.09.021